Cargando…

Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment

BACKGROUND: The Ministry of Health, Treatment and Medical Education of Iran has recently announced an estimated figure of 200,000 injecting drug users (IDUs). The aim of this study was to pilot a national program using demographics, types of drug abuse and prevalence of blood-borne infections among...

Descripción completa

Detalles Bibliográficos
Autores principales: ESKANDARIEH, Sharareh, NIKFARJAM, Ali, TARJOMAN, Termeh, NASEHI, Abassali, JAFARI, Firoozeh, SABERI-ZAFARGHANDI, Mohammad-Bagher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744255/
https://www.ncbi.nlm.nih.gov/pubmed/23967426
_version_ 1782280569115115520
author ESKANDARIEH, Sharareh
NIKFARJAM, Ali
TARJOMAN, Termeh
NASEHI, Abassali
JAFARI, Firoozeh
SABERI-ZAFARGHANDI, Mohammad-Bagher
author_facet ESKANDARIEH, Sharareh
NIKFARJAM, Ali
TARJOMAN, Termeh
NASEHI, Abassali
JAFARI, Firoozeh
SABERI-ZAFARGHANDI, Mohammad-Bagher
author_sort ESKANDARIEH, Sharareh
collection PubMed
description BACKGROUND: The Ministry of Health, Treatment and Medical Education of Iran has recently announced an estimated figure of 200,000 injecting drug users (IDUs). The aim of this study was to pilot a national program using demographics, types of drug abuse and prevalence of blood-borne infections among IDUs. METHODS: In order to elicit data on demographics, types of drug abuse and prevalence of blood-borne infections among IDUs, a questionnaire was designed in the Bureau of Mental-Social Health and Addiction in collaboration with Iran’s Drug Control Headquarters of the Police Department. Therapeutical alliance of addiction in Shafagh Center was based on Methadone Maintenance Therapy (MMT). RESULTS: Among 402 reported IDUs most of them were male, single and in age range of 20 to 39 years old with 72.7% history of imprisonment. Most of them had elementary and high school education and a history of addiction treatment. The majority were current users of opioid, heroin and crack. The prevalence of blood-borne infections was 65.9% and 18.8% for HCV and HIV/AIDS infections, respectively. CONCLUSION: Prevention programs about harm reduction, treatment and counseling should include young IDUs as a core focus of their intervention structure.
format Online
Article
Text
id pubmed-3744255
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-37442552013-08-21 Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment ESKANDARIEH, Sharareh NIKFARJAM, Ali TARJOMAN, Termeh NASEHI, Abassali JAFARI, Firoozeh SABERI-ZAFARGHANDI, Mohammad-Bagher Iran J Public Health Original Article BACKGROUND: The Ministry of Health, Treatment and Medical Education of Iran has recently announced an estimated figure of 200,000 injecting drug users (IDUs). The aim of this study was to pilot a national program using demographics, types of drug abuse and prevalence of blood-borne infections among IDUs. METHODS: In order to elicit data on demographics, types of drug abuse and prevalence of blood-borne infections among IDUs, a questionnaire was designed in the Bureau of Mental-Social Health and Addiction in collaboration with Iran’s Drug Control Headquarters of the Police Department. Therapeutical alliance of addiction in Shafagh Center was based on Methadone Maintenance Therapy (MMT). RESULTS: Among 402 reported IDUs most of them were male, single and in age range of 20 to 39 years old with 72.7% history of imprisonment. Most of them had elementary and high school education and a history of addiction treatment. The majority were current users of opioid, heroin and crack. The prevalence of blood-borne infections was 65.9% and 18.8% for HCV and HIV/AIDS infections, respectively. CONCLUSION: Prevention programs about harm reduction, treatment and counseling should include young IDUs as a core focus of their intervention structure. Tehran University of Medical Sciences 2013-06-01 /pmc/articles/PMC3744255/ /pubmed/23967426 Text en Copyright © Iranian Public Health Association & Tehran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
ESKANDARIEH, Sharareh
NIKFARJAM, Ali
TARJOMAN, Termeh
NASEHI, Abassali
JAFARI, Firoozeh
SABERI-ZAFARGHANDI, Mohammad-Bagher
Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment
title Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment
title_full Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment
title_fullStr Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment
title_full_unstemmed Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment
title_short Descriptive Aspects of Injection Drug Users in Iran’s National Harm Reduction Program by Methadone Maintenance Treatment
title_sort descriptive aspects of injection drug users in iran’s national harm reduction program by methadone maintenance treatment
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744255/
https://www.ncbi.nlm.nih.gov/pubmed/23967426
work_keys_str_mv AT eskandariehsharareh descriptiveaspectsofinjectiondrugusersiniransnationalharmreductionprogrambymethadonemaintenancetreatment
AT nikfarjamali descriptiveaspectsofinjectiondrugusersiniransnationalharmreductionprogrambymethadonemaintenancetreatment
AT tarjomantermeh descriptiveaspectsofinjectiondrugusersiniransnationalharmreductionprogrambymethadonemaintenancetreatment
AT nasehiabassali descriptiveaspectsofinjectiondrugusersiniransnationalharmreductionprogrambymethadonemaintenancetreatment
AT jafarifiroozeh descriptiveaspectsofinjectiondrugusersiniransnationalharmreductionprogrambymethadonemaintenancetreatment
AT saberizafarghandimohammadbagher descriptiveaspectsofinjectiondrugusersiniransnationalharmreductionprogrambymethadonemaintenancetreatment